US Stock MarketDetailed Quotes

RVLPQ RVL Pharmaceuticals

Watchlist

0.000
0.0000.00%

15min DelayClose May 28 09:30 ET

11.14KMarket Cap0.00P/E (TTM)

RVL Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-704.31%-12.06M

56.18%-5.82M

30.92%-37.81M

32.64%-16.43M

36.61%-10.1M

168.31%2M

-15.58%-13.28M

-411.15%-54.73M

-195.63%-24.4M

-137.03%-15.93M

Net income from continuing operations

-97.33%-23.89M

-70.24%-11.61M

20.38%-51.69M

7.11%-18.32M

19.11%-14.45M

31.71%-12.11M

29.04%-6.82M

18.43%-64.92M

64.06%-19.72M

-106.87%-17.86M

Operating gains losses

74.60%-892K

-116.91%-756K

72.47%-2.15M

-121.26%-7.5M

29,413.33%4.4M

-381.64%-3.51M

179.29%4.47M

-2,817.07%-7.8M

-56,616.67%-3.39M

-121.74%-15K

Depreciation and amortization

3.30%94K

4.49%93K

-95.41%375K

-6.54%100K

-38.31%95K

-97.68%91K

-97.77%89K

-61.12%8.18M

-97.59%107K

-99.05%154K

Deferred tax

-442.86%-48K

22.22%11K

53.61%-90K

-814.29%-128K

103.36%15K

-92.39%14K

-89.16%9K

83.22%-194K

92.31%-14K

73.01%-447K

Other non cash items

181.17%1M

805.47%5.13M

-402.06%-6.02M

-109.45%-400K

-75.26%-4.96M

-494.87%-1.23M

104.69%567K

12.97%1.99M

1,390.85%4.23M

-334.58%-2.83M

Change In working capital

-114.03%-2.46M

106.35%813K

158.78%4.39M

33.64%-4.39M

357.24%4.04M

64,833.33%17.53M

-626.04%-12.8M

-301.88%-7.46M

17.75%-6.61M

-91.67%884K

-Change in receivables

-100.34%-53K

107.46%1.15M

-112.63%-898K

-89.90%249K

-288.41%-1.45M

27,036.21%15.74M

-504.48%-15.44M

-59.37%7.11M

150.90%2.47M

-96.62%768K

-Change in inventory

-468.71%-1.14M

--571K

-97.92%54K

-148.08%-163K

-114.31%-93K

-67.40%310K

--0

-23.02%2.6M

-91.01%339K

182.17%650K

-Change in prepaid assets

-90.14%315K

1,090.00%5M

169.10%4.28M

40.46%-1.36M

169.50%2.03M

232.97%3.19M

-69.96%420K

-93.14%-6.2M

71.33%-2.28M

-191.26%-2.92M

-Change in payables and accrued expense

7.77%-1.58M

-366.25%-5.91M

108.64%948K

56.33%-3.12M

49.35%3.56M

-220.49%-1.71M

129.07%2.22M

43.80%-10.97M

-823.73%-7.14M

116.43%2.38M

Cash from discontinued investing activities

Operating cash flow

-704.31%-12.06M

56.18%-5.82M

30.92%-37.81M

32.64%-16.43M

36.61%-10.1M

168.31%2M

-15.58%-13.28M

-411.15%-54.73M

-195.63%-24.4M

-266.95%-15.93M

Investing cash flow

Cash flow from continuing investing activities

-1,782.46%-959K

-12,350.00%-1.23M

-97.75%126K

-129.33%-172K

194.67%231K

105.97%57K

-99.85%10K

281.84%5.61M

89.47%-75K

64.74%-244K

Net PPE purchase and sale

-1,782.46%-959K

-12,350.00%-1.23M

107.45%126K

-129.33%-172K

194.67%231K

105.97%57K

102.39%10K

45.14%-1.69M

89.47%-75K

64.74%-244K

Net intangibles purchase and sale

----

--0

----

--7.3M

--0

Cash from discontinued investing activities

Investing cash flow

-1,782.46%-959K

-12,350.00%-1.23M

-99.89%126K

-129.33%-172K

-99.79%231K

105.97%57K

-99.85%10K

3,876.04%116.45M

89.47%-75K

16,082.80%110.6M

Financing cash flow

Cash flow from continuing financing activities

53.11%-460K

-480.65%-4.86M

130.87%41.78M

-97.53%1.4M

122.68%42.21M

82.35%-981K

-254.66%-837K

-3,775.45%-135.33M

1,938.82%56.56M

-704.50%-186.1M

Net issuance payments of debt

51.16%-443K

-442.83%-4.88M

110.83%18.1M

-94.11%1.43M

109.93%18.48M

82.92%-907K

-5,518.75%-899K

-233.54%-167.19M

83,551.72%24.2M

-271.90%-186.07M

Net common stock issuance

--0

-22.69%92K

-27.09%23.63M

-100.06%-21K

--23.54M

--0

--119K

-40.35%32.41M

1,091.37%32.38M

----

Proceeds from stock option exercised by employees

----

-18.03%191K

--0

----

6.39%233K

-100.46%-1K

--95K

Net other financing activities

77.03%-17K

-26.32%-72K

81.74%-143K

43.75%-9K

98.13%-3K

70.28%-74K

84.08%-57K

-4.54%-783K

---16K

---160K

Cash from discontinued financing activities

Financing cash flow

53.11%-460K

-480.65%-4.86M

130.87%41.78M

-97.53%1.4M

122.68%42.21M

82.35%-981K

-254.66%-837K

-3,775.45%-135.33M

1,938.82%56.56M

-704.50%-186.1M

Net cash flow

Beginning cash position

23.91%32.64M

10.14%44.54M

-64.54%40.44M

615.42%59.75M

-72.53%27.41M

-75.88%26.34M

-64.54%40.44M

18.97%114.05M

-93.38%8.35M

-28.92%99.78M

Current changes in cash

-1,357.56%-13.48M

15.60%-11.9M

105.57%4.1M

-147.39%-15.21M

135.37%32.34M

111.36%1.07M

-191.32%-14.1M

-504.71%-73.61M

366.54%32.09M

-540.10%-91.43M

End cash Position

-30.11%19.16M

23.91%32.64M

10.14%44.54M

615.42%59.75M

-72.53%27.41M

-75.88%26.34M

-64.54%40.44M

-93.38%8.35M

Free cash flow

-756.71%-13.11M

46.46%-7.12M

31.77%-38.56M

30.13%-17.13M

37.47%-10.12M

151.21%2M

-11.71%-13.3M

-490.94%-56.51M

-173.54%-24.52M

-282.96%-16.19M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-704.31%-12.06M	56.18%-5.82M	30.92%-37.81M	32.64%-16.43M	36.61%-10.1M	168.31%2M	-15.58%-13.28M	-411.15%-54.73M	-195.63%-24.4M	-137.03%-15.93M
Net income from continuing operations	-97.33%-23.89M	-70.24%-11.61M	20.38%-51.69M	7.11%-18.32M	19.11%-14.45M	31.71%-12.11M	29.04%-6.82M	18.43%-64.92M	64.06%-19.72M	-106.87%-17.86M
Operating gains losses	74.60%-892K	-116.91%-756K	72.47%-2.15M	-121.26%-7.5M	29,413.33%4.4M	-381.64%-3.51M	179.29%4.47M	-2,817.07%-7.8M	-56,616.67%-3.39M	-121.74%-15K
Depreciation and amortization	3.30%94K	4.49%93K	-95.41%375K	-6.54%100K	-38.31%95K	-97.68%91K	-97.77%89K	-61.12%8.18M	-97.59%107K	-99.05%154K
Deferred tax	-442.86%-48K	22.22%11K	53.61%-90K	-814.29%-128K	103.36%15K	-92.39%14K	-89.16%9K	83.22%-194K	92.31%-14K	73.01%-447K
Other non cash items	181.17%1M	805.47%5.13M	-402.06%-6.02M	-109.45%-400K	-75.26%-4.96M	-494.87%-1.23M	104.69%567K	12.97%1.99M	1,390.85%4.23M	-334.58%-2.83M
Change In working capital	-114.03%-2.46M	106.35%813K	158.78%4.39M	33.64%-4.39M	357.24%4.04M	64,833.33%17.53M	-626.04%-12.8M	-301.88%-7.46M	17.75%-6.61M	-91.67%884K
-Change in receivables	-100.34%-53K	107.46%1.15M	-112.63%-898K	-89.90%249K	-288.41%-1.45M	27,036.21%15.74M	-504.48%-15.44M	-59.37%7.11M	150.90%2.47M	-96.62%768K
-Change in inventory	-468.71%-1.14M	--571K	-97.92%54K	-148.08%-163K	-114.31%-93K	-67.40%310K	--0	-23.02%2.6M	-91.01%339K	182.17%650K
-Change in prepaid assets	-90.14%315K	1,090.00%5M	169.10%4.28M	40.46%-1.36M	169.50%2.03M	232.97%3.19M	-69.96%420K	-93.14%-6.2M	71.33%-2.28M	-191.26%-2.92M
-Change in payables and accrued expense	7.77%-1.58M	-366.25%-5.91M	108.64%948K	56.33%-3.12M	49.35%3.56M	-220.49%-1.71M	129.07%2.22M	43.80%-10.97M	-823.73%-7.14M	116.43%2.38M
Cash from discontinued investing activities
Operating cash flow	-704.31%-12.06M	56.18%-5.82M	30.92%-37.81M	32.64%-16.43M	36.61%-10.1M	168.31%2M	-15.58%-13.28M	-411.15%-54.73M	-195.63%-24.4M	-266.95%-15.93M
Investing cash flow
Cash flow from continuing investing activities	-1,782.46%-959K	-12,350.00%-1.23M	-97.75%126K	-129.33%-172K	194.67%231K	105.97%57K	-99.85%10K	281.84%5.61M	89.47%-75K	64.74%-244K
Net PPE purchase and sale	-1,782.46%-959K	-12,350.00%-1.23M	107.45%126K	-129.33%-172K	194.67%231K	105.97%57K	102.39%10K	45.14%-1.69M	89.47%-75K	64.74%-244K
Net intangibles purchase and sale	----	----	--0	--0	----	----	----	--7.3M	--0	--0
Cash from discontinued investing activities
Investing cash flow	-1,782.46%-959K	-12,350.00%-1.23M	-99.89%126K	-129.33%-172K	-99.79%231K	105.97%57K	-99.85%10K	3,876.04%116.45M	89.47%-75K	16,082.80%110.6M
Financing cash flow
Cash flow from continuing financing activities	53.11%-460K	-480.65%-4.86M	130.87%41.78M	-97.53%1.4M	122.68%42.21M	82.35%-981K	-254.66%-837K	-3,775.45%-135.33M	1,938.82%56.56M	-704.50%-186.1M
Net issuance payments of debt	51.16%-443K	-442.83%-4.88M	110.83%18.1M	-94.11%1.43M	109.93%18.48M	82.92%-907K	-5,518.75%-899K	-233.54%-167.19M	83,551.72%24.2M	-271.90%-186.07M
Net common stock issuance	--0	-22.69%92K	-27.09%23.63M	-100.06%-21K	--23.54M	--0	--119K	-40.35%32.41M	1,091.37%32.38M	----
Proceeds from stock option exercised by employees	----	----	-18.03%191K	--0	----	----	----	6.39%233K	-100.46%-1K	--95K
Net other financing activities	77.03%-17K	-26.32%-72K	81.74%-143K	43.75%-9K	98.13%-3K	70.28%-74K	84.08%-57K	-4.54%-783K	---16K	---160K
Cash from discontinued financing activities
Financing cash flow	53.11%-460K	-480.65%-4.86M	130.87%41.78M	-97.53%1.4M	122.68%42.21M	82.35%-981K	-254.66%-837K	-3,775.45%-135.33M	1,938.82%56.56M	-704.50%-186.1M
Net cash flow
Beginning cash position	23.91%32.64M	10.14%44.54M	-64.54%40.44M	615.42%59.75M	-72.53%27.41M	-75.88%26.34M	-64.54%40.44M	18.97%114.05M	-93.38%8.35M	-28.92%99.78M
Current changes in cash	-1,357.56%-13.48M	15.60%-11.9M	105.57%4.1M	-147.39%-15.21M	135.37%32.34M	111.36%1.07M	-191.32%-14.1M	-504.71%-73.61M	366.54%32.09M	-540.10%-91.43M
End cash Position	-30.11%19.16M	23.91%32.64M	10.14%44.54M	10.14%44.54M	615.42%59.75M	-72.53%27.41M	-75.88%26.34M	-64.54%40.44M	-64.54%40.44M	-93.38%8.35M
Free cash flow	-756.71%-13.11M	46.46%-7.12M	31.77%-38.56M	30.13%-17.13M	37.47%-10.12M	151.21%2M	-11.71%-13.3M	-490.94%-56.51M	-173.54%-24.52M	-282.96%-16.19M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall